LOX and cancer: In vivo and in vitro data in mice and mouse cancer cells suggest a feedback pathway in which Gln LOX-PP has lost the ability to inhibit LOX expression, while wildtype Arg LOX-PP maintains a more normal LOX expression in a negative feedback pathway.